What is PTHS's u.s.patents covering ZELSUVMI — number of patents?

PTHS (PTHS) reported u.s.patents covering ZELSUVMI — number of patents of 14 in Q1 2026.

What does u.s.patents covering ZELSUVMI — number of patents mean?

This metric represents the total count of active U.S. patents specifically protecting the intellectual property, formulation, or therapeutic application of the ZELSUVMI product candidate. It serves as a key indicator of the company's competitive moat and the legal exclusivity period available for commercialization within the U.S. market. Investors use this to assess the durability of the product's market position and the strength of the company's defensive intellectual property strategy.

PTHS PTHS U.S.Patents Covering ZELSUVMI — Number of patents

Similar metrics at other companies

IDNUnited States — Number of patents

10—

RGNXZolgensma Royalties — Number Of Countries Where Licensed Patents Remain Active

20—

JAZZXywav — Number of patents, paragraph IV certification notice filed

15—

SMRNumber of patents

30.0%

JAZZXyrem — Number of patents, paragraph IV certification notice filed

7—

BMRNVIMIZIM — Total revenues

$210.2M+11.6%

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+75.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept pths:NumberOfPatentsObtained.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's u.s.patents covering zelsuvmi — number of patents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's u.s.patents covering ZELSUVMI — number of patents?: PTHS (PTHS) reported u.s.patents covering ZELSUVMI — number of patents of 14 in Q1 2026.
What does u.s.patents covering ZELSUVMI — number of patents mean?: This metric represents the total count of active U.S. patents specifically protecting the intellectual property, formulation, or therapeutic application of the ZELSUVMI product candidate. It serves as a key indicator of the company's competitive moat and the legal exclusivity period available for commercialization within the U.S. market. Investors use this to assess the durability of the product's market position and the strength of the company's defensive intellectual property strategy.